Background: Abnormal immune activation persists in most HIV-infected individuals despite prolonged antiretroviral therapy (ART)-mediated viral suppression, and predicts increased morbidity and mortality, but the specific immunologic pathways predicting disease remain incompletely defined, particularly in resource-limited settings. Plasma kynurenine/tryptophan (KT) ratio, a marker of indoleamine 2,3-dioxygenase-1 (IDO) activity, strongly predicts mortality in this setting, but whether it is simply a marker for other immunologic pathways is unclear.
Methods: We sampled the first 542 HIV-infected Ugandans initiating ART in the UARTO cohort and measured plasma KT ratio, D-dimer, IL-6, sCD163, sCD14, and T cell activation (%HLA-DR+CD38+) at baseline and month 6 of ART-mediated viral suppression (<400 copies/ml). Predictors of mortality were assessed with Cox proportional hazards models, adjusted for age, body mass index, and pre-ART CD4+T cell count.
Results: Participants were mostly female (70%) with a median age of 34, and had advanced disease (median baseline CD4+ count 140 cells/mm3 and HIV RNA 5.0 log10copies/mL) at ART initiation. A total of 43 deaths occurred during a median 7 years of follow-up, with just 10% LTFU at 7 years. As previously reported, both pre-ART and month 6 KT ratio predicted increased mortality. In addition, pre-ART D-dimer, IL-6, and sCD14 were associated with increased mortality in unadjusted and adjusted models. After 6 months of ART-mediated suppression, IL-6 and sCD14 remained significant predictors of mortality, but CD4+ and CD8+ T cell activation were associated with even greater risks of death. However, further adjustment for KT ratio rendered mortality associations with all other biomarkers non-significant. The association between KT ratio and mortality persisted despite adjustment for all other biomarkers, with the possible exception of IL-6 at month 6 (HR 1.75, 95% CI 1.00, 3.01).
Conclusions: The immunologic pathways predicting mortality among HIV-infected Ugandans may be different than those described in resource-rich settings. IDO and T cell activation may have a greater impact during early ART in resource-limited settings where opportunistic infections remain an important cause of death. These findings also suggest that monocyte (sCD14) and T cell activation may predict mortality via the same causal pathways as IDO, while IL-6 may predict mortality via overlapping but potentially distinct pathways.